Expanded Health Insurance Benefit of ‘Invega Sustenna’
Janssen Korea(CEO Ok-yeon Kim) announced the health insurance standard of Invega Sustenna(generic name: paliperidone palmitate), a schizophrenia treatment, will be changed from the 1st under the Ministry of Health and Welfare’s revision notice for the ‘Details of Health Insurance Application Stan...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
